Hanke Christiane R, Grijalva Carlos G, Chochua Sopio, Pletz Mathias W, Hornberg Claudia, Edwards Kathryn M, Griffin Marie R, Verastegui Hector, Gil Ana I, Lanata Claudio F, Klugman Keith P, Vidal Jorge E
From the *Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia; †Department of Health Policy, School of Medicine, Vanderbilt University, Nashville, Tennessee; ‡Center for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany; §Department of Environment and Health, School of Public Health, Bielefeld University, Bielefeld, Germany, ¶Vanderbilt Vaccine Research Program, Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee; and ‖Instituto de Investigación Nutricional, Lima, Perú.
Pediatr Infect Dis J. 2016 Apr;35(4):432-9. doi: 10.1097/INF.0000000000001030.
Pneumococcal conjugate vaccines (PCV) have decreased nasopharyngeal carriage of vaccine types but little data exist from rural areas. We investigated bacterial density, serotype distribution and antibiotic resistance of pneumococcal strains within the nasopharynx of young children in the Peruvian Andes, 2 years after PCV7 was introduced.
Pneumococcal strains were isolated from a subset of 125 children from our Peruvian cohort, who entered the study in 2009 and had pneumococcus detected in the nasopharynx in both 2009 and during follow-up in 2011. Strains were Quellung serotyped and tested for susceptibility to antibiotics. Bacterial density was determined by quantitative polymerase chain reaction.
The prevalence of PCV7 strains decreased from 48% in 2009 to 28.8% in 2011, whereas non-PCV7 types increased from 52% to 71.2% (P = 0.002). There was a 3.5-fold increase in carriage of serotype 6C in 2011 (P = 0.026). Vaccination with PCV7 did not affect pneumococcal density in children colonized by a PCV7 type but did increase density in those colonized with a non-PCV7 type. Antibiotic resistance did not change after vaccine introduction; strains were nonsusceptible to tetracycline (97.2%), trimethoprim-sulfamethoxazole (56.4%), penicillin (34%), erythromycin (22.4%), chloramphenicol (18.8%) and clindamycin (12.4%).
Serotype replacement was observed post-PCV7 vaccination with a concomitant, not previously recognized, increased nasopharyngeal density.
肺炎球菌结合疫苗(PCV)已降低了疫苗型别在鼻咽部的携带率,但农村地区的数据较少。我们调查了在引入PCV7两年后,秘鲁安第斯地区幼儿鼻咽部肺炎球菌菌株的细菌密度、血清型分布及抗生素耐药性。
从我们秘鲁队列中的125名儿童亚组中分离出肺炎球菌菌株,这些儿童于2009年进入研究,在2009年及2011年随访期间均在鼻咽部检测到肺炎球菌。对菌株进行荚膜肿胀试验血清分型并检测其对抗生素的敏感性。通过定量聚合酶链反应确定细菌密度。
PCV7菌株的携带率从2009年的48%降至2011年的28.8%,而非PCV7型别从52%增至71.2%(P = 0.002)。2011年6C血清型的携带率增加了3.5倍(P = 0.026)。接种PCV7对由PCV7型别定植的儿童的肺炎球菌密度没有影响,但确实增加了由非PCV7型别定植儿童的密度。引入疫苗后抗生素耐药性未发生变化;菌株对四环素不敏感(97.2%)、对甲氧苄啶 - 磺胺甲恶唑不敏感(56.4%)、对青霉素不敏感(34%)、对红霉素不敏感(22.4%)、对氯霉素不敏感(18.8%)以及对克林霉素不敏感(12.4%)。
在接种PCV7疫苗后观察到血清型替换,同时出现了此前未被认识到的鼻咽部密度增加。